Biohaven Ltd.
BHVN
$14.71
-$0.39-2.58%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -221.68M | -186.84M | -160.30M | -319.77M | -179.50M |
| Total Depreciation and Amortization | 2.25M | 2.46M | 1.99M | 1.95M | 1.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.67M | 19.66M | -3.48M | 173.33M | 49.80M |
| Change in Net Operating Assets | -4.37M | -6.02M | 20.52M | -23.31M | 25.62M |
| Cash from Operations | -165.12M | -170.74M | -141.28M | -167.80M | -102.64M |
| Capital Expenditure | -461.00K | -49.00K | -611.00K | -2.95M | -440.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 391.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 165.34M | -87.63M | -92.79M | -94.98M | 34.08M |
| Cash from Investing | 164.88M | -87.68M | -93.40M | -97.93M | 34.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 369.00K | 282.79M | 76.36M | 316.32M | 2.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -9.93M | 4.01M | 4.81M | 1.22M |
| Cash from Financing | 369.00K | 272.85M | 80.38M | 321.12M | 3.42M |
| Foreign Exchange rate Adjustments | 23.00K | 88.00K | 0.00 | -7.00K | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.00K | 14.52M | -154.30M | 55.39M | -65.19M |